Document Detail


Single-incision sling system as primary treatment of female stress urinary incontinence: prospective 12 months data from a single institution.
MedLine Citation:
PMID:  21457429     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Study Type - Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? Single-incision slings (SIS), requiring very limited intracorporeal dissection, have been recently introduced on the premise that they might increase safety of female stress urinary incontinence treatment. However, their success rate has been insufficiently evaluated. This is a large prospective series on Mini-Arc SIS, with data on 105 patients available at a mean follow-up of 12 months. Success rates are comparable while morbidity was lower and milder than that associated retropubic or transobturator slings. This study warrants a large-scale randomized comparative study between Mini-Arc and standard mid-urethral tapes, matured at longer follow-up time. OBJECTIVE: To investigate the success and complication rates for Mini-Arc(TM) single incision sling in the treatment of female stress urinary incontinence (SUI). MATERIALS AND METHODS: A total of 119 female patients with pure SUI were enrolled in a prospective study. From these, 105 were available with a minimum follow-up of 6 months and a mean follow-up of 12 months. Success, as determined by patient- reported outcomes, and complication rates, as well as impact of learning curve, body mass index (BMI), intrinsic sphincter deficiency (ISD), incontinence severity and age were investigated. RESULTS: Cure rate was 80% and improvement rate was 11%. Pain intensity was minimal on a visual analogue scale and transient urinary retention occurred in three patients, one requiring sling section. De novo urgency was reported by 6% of women. Severe incontinence was less likely to be cured: 70% if >5 pads per day (ppd); 94% if <2 ppd; 94% if 2-4 ppd, P < 0.05). There was no difference in success rates between the first 50 and the last 50 patients. BMI, ISD and age also did not influence success rate. CONCLUSION: Mini-Arc(TM) attained high success rates at 1 year follow-up. The procedure was easy to learn and was associated with very low and mild morbidity. Severe incontinence was identified as a risk factor for failure.
Authors:
Rui Oliveira; Francisco Botelho; Pedro Silva; Alexandre Resende; Carlos Silva; Paulo Dinis; Francisco Cruz
Related Documents :
2091439 - Levamisole treatment of oligospermia.
21266319 - Single-boosted protease inhibitor versus double-boosted protease inhibitors for the sal...
21497049 - Simultaneous bilateral versus sequential bilateral cataract surgery helsinki simultaneo...
21362109 - An ultrapure plasma-derived monoclonal antibody-purified factor ix concentrate (nonafac...
21431319 - Non-cutting setons for progressive migration of complex fistula tracts: a new spin on a...
19674359 - How frequent is adenoid obstruction? impact on the diagnostic approach.
12756159 - Combined steroid treatment for congenital heart surgery improves oxygen delivery and re...
14998499 - Steroids in adults with acute bacterial meningitis: a systematic review.
6684829 - Chemotherapeutic treatment of naturally acquired generalized demodicosis.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-1
Journal Detail:
Title:  BJU international     Volume:  -     ISSN:  1464-410X     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100886721     Medline TA:  BJU Int     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.
Affiliation:
Hospital de São João, Serviço de Urologia, Porto, Portugal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose-dependently reduces calcul...
Next Document:  CD4+ and CD8+ T-lymphocyte scores cannot reliably predict progression in patients with benign prosta...